Across TCGA pan-cancer cohorts, LINC02875 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of LINC02875’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where LINC02875 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02875 is over-expressed in tumor, although a few such as LUAD and UCEC show the opposite, repressed pattern.
COAD, LIHC, and STAD are the cancer types where LINC02875 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02875 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.